We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 6.91% | 2.165 | 2.05 | 2.28 | 2.29 | 1.995 | 2.00 | 4,381,830 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/5/2020 15:55 | Nobby was once accused and supposedly caught off guard being multiple posters on here, Marie /oi oi lads/don't fly could just be more of his fun. Maybe he just got fed up of Being Ken Chung and himself. I would. Also I don't get why our local resident genius hasn't been called upon to assist with the covid situation? Our Sylvianne Muller has! | brad44 | |
03/5/2020 15:11 | Once you get Marie's personality..her post are a fun read | halfbutt | |
03/5/2020 15:01 | The people that matter believe the data is strong enough to get Lupuzor into phase 3. | wigwammer | |
03/5/2020 10:24 | Spot on Nobby as usual.. Let’s bloodbath commence.. But IMM at 8p no brainer and sell at 15p Rinse n repeat until IMM cross 19p with volume | idontflykathyy | |
03/5/2020 08:40 | I have just read the IMM full year report all the way through and am shocked at some of the statements in there about Lupuzor. I paste one paragraph below which was particularly shocking. How can they possibly say 'based on the strong data already gained within ImmuPharma's lupus dossier'. The drug spectacularly failed and has never passed a primary endpoint in any trial which was run to the end. If I was a shareholder I would be taking the company to task for such erroneous statements. All just IMHO and DYOR.... 'Certain autoimmune indications, outside of lupus, have the potential for Orphan Drug designation. One disease of key interest to ImmuPharma's team is Chronic Inflammatory Demyelinating Polyneuropathy ("CIDP"). CIDP is a neurological disorder targeting the body's nerves. Further assessment continues with the objective of moving CIDP forward into a Proof of Concept study, based on the strong data already gained within ImmuPharma's lupus dossier.' | nobbygnome | |
03/5/2020 08:26 | Completely agree. There was nothing in the disappointing results statement to stop the price drifting off. | nobbygnome | |
02/5/2020 12:29 | Relevant IMM information on it's thread at last - thanks also. | daveboy1 | |
01/5/2020 23:34 | Thanks. Interesting. | cumnor | |
01/5/2020 23:32 | That's what it says.... hxxps://www.immuphar | tarny | |
01/5/2020 22:21 | Sylviane Muller Tarny??? | cumnor | |
01/5/2020 22:16 | Just seen this on the lse site - Sylviane Muller one of the 12 researchers.... Emmanuel Macron will install Tuesday at 5:00 p.m. at the Elysée the Research and Expertise Analysis Committee (Care), which brings together 12 researchers and doctors to advise the government on treatments and tests against the coronavirus, the presidency said. Here is the composition of the Care: - Françoise Barré-Sinoussi : president. Virologist, Nobel Prize, Institut Pasteur / Inserm. - Jean-Philippe Spano : oncologist. Department head of the medical oncology department at the Pitié-Salpétrière hospital (Paris). - Yazdan Yazdanpanah : infectiologist-epide - Franck Molina: researcher at CNRS. Director of the UMR Sys2Diag in Montpellier. Specialist in diagnostic technologies and monoclonal antibodies. - Dominique Valeyre: professor of pulmonology at the Avicenne hospital in Bobigny. Former head of the pneumology department. - Bertrand Thirion: researcher at Inria. Director of the DataIA convergence institute, specialist in data science-artificial intelligence applied to the field. - Sylviane Muller: researcher at CNRS. Immunologist. Former scientific assistant director of the CNRS. Discoverer of a treatment for lupus, awarded the CNRS Innovation Medal. - Laetitia Atlani-Duault: researcher at IRD. Anthropologist, expert at the UN, specialist in crisis management, humanitarian aid. Also a member of the scientific council on the Covid-19. - Marie-Paule Kieny: researcher at Inserm, infectious disease specialist . Former WHO Deputy Director. - Muriel Vayssier: Director of the Animal Health Department of INRA. Lyme disease specialist. - Marc Lecuit: professor of infectious diseases, assistant director of the department of infectious and tropical diseases at the Necker Hospital, and director of the Biology of Infections unit at the Pasteur Institute. - Christophe Junot: head of the drugs and technologies for health department at CEA. | tarny | |
01/5/2020 20:09 | And a nice 500 plus fall on the Dow. Happy days.... | nobbygnome | |
01/5/2020 17:20 | Nice Nobby.. I can see IMM corrected. 10p easy now with more broad correction on the way. Even 8p can’t be ruled out but have feeling there is not much scope of correction for IMM below 8p. 10p sure shot. And then once should again take advantage | idontflykathyy | |
01/5/2020 15:04 | Closed my short at 12.8; a nice little profit in 24 hours! | nobbygnome | |
01/5/2020 12:08 | And we're all delighted for you nobby. Good to see you've got your priorities right as always. | lord loads of lolly | |
01/5/2020 10:28 | Yes my spreadbet account is filling up with cash again! | nobbygnome | |
01/5/2020 08:11 | Lovely red day out there... nice: And well volatility index up just 30%. More to come.:: let the bloodbath commence.. | idontflykathyy | |
01/5/2020 04:40 | What a glorious day today.. all futures red! Bloodbath | idontflykathyy | |
30/4/2020 21:53 | Cheers Nobby, Loving this fall and to be honest it was due. I literally changed couple of points in my Fibonacci chart to accommodate this rise but all now points to southwards. Apple and Amazon came up with horrible results and both down 5%. Another glorious day awaits tomorrow. Member like Dave won’t understand that to rise it need 100% but crash need just 50%. Anyway, yup I’m not adding IMM. Come 8-10 p and I think. Be in touch.. | idontflykathyy | |
30/4/2020 20:44 | Lamentable, Nob. | daveboy1 | |
30/4/2020 17:54 | Just a deluge of sellers | amaretto1 | |
30/4/2020 17:02 | >> Marie Great to see the Dow plummeting at last. It really couldn't defy gravity any longer. And talking of shorting, I took out a small short here today at 14p. Didn't get the top but good enough. The lack of any progress with the FDA means this will drift lower at best. Just IMHO of course... | nobbygnome | |
30/4/2020 14:43 | Volatility index up 15% - what's like in 2-3 hours ?! One should always trade this index. Bit wild but worth it. | idontflykathyy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions